Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P4HTM | Q9NXG6 | 14/20 | 0.62 |
| ▸ | P4HA1 | P13674 | 1/20 | 0.53 |
| ▸ | MIF | P14174 | 1/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.52 |
| ▸ | L3MBTL1 | Q9Y468 | 4/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | PKM | P14618 | 1/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.46 |
| ▸ | THPO | P40225 | 1/20 | 0.46 |
| ▸ | BLM | P54132 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4144524 | 0.82 | P4HTM (0.43) | P4HTMP4HA1MIFKDM4EALDH1A1 | |
| SCHEMBL14313758 | 0.82 | KMT2A (0.49) | P4HTMP4HA1MIFALDH1A1KMT2A | |
| SCHEMBL515603 | 0.82 | P4HTM (0.65) | P4HTMP4HA1MIFKDM4EALDH1A1 | |
| SCHEMBL27623809 | 0.79 | P4HTM (0.41) | P4HTMP4HA1MIFKDM4EALDH1A1 | |
| SCHEMBL18573317 | 0.78 | P4HTM (0.71) | P4HTMP4HA1MIFKDM4EALDH1A1 | |
| SCHEMBL3242056 | 0.78 | MAPK1 (0.59) | P4HTMKDM4EALDH1A1L3MBTL1LMNA | |
| SCHEMBL8266390 | 0.77 | GABRA1 (0.43) | P4HTMKDM4EALDH1A1L3MBTL1KMT2A | |
| SCHEMBL128459 | 0.76 | P4HTM (0.67) | P4HTMP4HA1MIFKDM4EALDH1A1 | |
| SCHEMBL10432643 | 0.76 | P4HTM (0.62) | P4HTMP4HA1MIFKDM4EALDH1A1 | |
| SCHEMBL9000504 | 0.76 | P4HTM (0.67) | P4HTMP4HA1MIFKDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 78 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260078113-A1 | HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS | INCYTE CORP (US) | 2026-03-19 | — | — | US | disclosed |
| US-12516044-B2 | Heterocyclic compounds as immunomodulators | INCYTE CORPORATION (US) | 2026-01-06 | — | — | US | disclosed |
| EP-4353759-A1 | PRODUCTION METHOD FOR AQUEOUS FLUORINE-CONTAINING ELASTOMER DISPERSION, COMPOSITION, AND AQUEOUS DISPERSION | Daikin Industries, Ltd. (JP) | 2024-04-17 | — | — | EP | disclosed |
| CN-117529511-A | Method for producing aqueous dispersion of fluoroelastomer, composition, and aqueous dispersion | 大金工业株式会社 | 2024-02-06 | — | — | CN | disclosed |
| US-20230192924-A1 | METHOD FOR PRODUCING FLUORINE-CONTAINING ELASTOMER AQUEOUS DISPERSION AND FLUORINE-CONTAINING ELASTOMER AQUEOUS DISPERSION | DAIKIN INDUSTRIES, LTD. (JP) | 2023-06-22 | — | — | US | disclosed |
| EP-4194474-A1 | METHOD FOR PRODUCING AQUEOUS DISPERSION OF FLUORINE-CONTAINING ELASTOMER | Daikin Industries, Ltd. (JP) | 2023-06-14 | — | — | EP | disclosed |
| EP-4186932-A1 | METHOD FOR PRODUCING FLUORINE-CONTAINING ELASTOMER AQUEOUS DISPERSION AND FLUORINE-CONTAINING ELASTOMER AQUEOUS DISPERSION | Daikin Industries, Ltd. (JP) | 2023-05-31 | — | — | EP | disclosed |
| CN-116171291-A | Method for producing aqueous dispersion of fluoroelastomer, and aqueous dispersion of fluoroelastomer | 大金工业株式会社 | 2023-05-26 | — | — | CN | disclosed |
| WO-2022260139-A1 | PRODUCTION METHOD FOR AQUEOUS FLUORINE-CONTAINING ELASTOMER DISPERSION, COMPOSITION, AND AQUEOUS DISPERSION | ダイキン工業株式会社 | 2022-12-15 | — | — | WO | disclosed |
| US-20220340893-A1 | BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES | NUEVOLUTION A/S (DK) | 2022-10-27 | — | — | US | disclosed |
| WO-2009055828-A1 | NEW TETRACYCLIC COMPOUNDS | MEDIVATION TECHNOLOGIES, INC. (US) | 2009-04-30 | — | — | WO | disclosed |
| US-20090096353-A1 | LIGHT EMITTING POLYMER MATERIAL, ORGANIC ELECTROLUMINESCENCE DEVICE AND DISPLAY DEVICE COMPRISING LIGHT EMITTING POLYMER MATERIAL | SHOWA DENKO K.K. (JP) | 2009-04-16 | — | — | US | disclosed |
| EP-1902076-A1 | LIGHT EMITTING POLYMER MATERIAL, ORGANIC ELECTROLUMINESCENCE DEVICE AND DISPLAY DEVICE COMPRISING LIGHT EMITTING POLYMER MATERIAL | Showa Dendo K.K. (JP) | 2008-03-26 | — | — | EP | disclosed |
| US-20080070928-A1 | Novel 2-Heteroaryl-Substituted Benzimidazole Derivative | MSD K.K. (JP) | 2008-03-20 | — | — | US | disclosed |
| CN-1926127-A | Novel 2-heteroaryl substituted benzimidazole derivatives | BANYU PHARMA CO LTD (JP) | 2007-03-07 | — | — | CN | disclosed |
| WO-2006135076-A1 | LIGHT EMITTING POLYMER MATERIAL, ORGANIC ELECTROLUMINESCENCE DEVICE AND DISPLAY DEVICE COMPRISING LIGHT EMITTING POLYMER MATERIAL | SHOWA DENKO K.K. (JP) | 2006-12-21 | — | — | WO | disclosed |
| EP-1702919-A1 | NOVEL 2-HETEROARYL-SUBSTITUTED BENZIMIDAZOLE DERIVATIVE | BANYU PHARMACEUTICAL CO., LTD. (JP) | 2006-09-20 | — | — | EP | disclosed |
| WO-2006056930-A2 | NOVEL 4 -AMINOPIPERIDINE DERIVATIVES AS PLASMEPSIN II INHIBITORS | ACTELION PHARMACEUTICALS LTD (CH) | 2006-06-01 | — | — | WO | disclosed |
| EP-1484381-A1 | PHOSPHORS, PROCESS FOR PRODUCTION THEREOF, PHOSPHORESCENT COMPOSITIONS AND ARTICLES MADE BY USING THE SAME | JSR Corporation (JP) | 2004-12-08 | — | — | EP | disclosed |
| US-20040106006-A1 | Phosphors, process for production thereof, phosphorescent compositions and articles made by using the same | JSR CORPORATION (JP) | 2004-06-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080070928-A1 | Novel 2-Heteroaryl-Substituted Benzimidazole Derivative | GCK, GCKR, HK1 | P4HTM 4396/4885P4HA1 2836/4885MIF 2704/4885 |
| US-20260078113-A1 | HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS | MSR1, NR3C1, CCR1 | P4HTM 3649/4885P4HA1 1945/4885MIF 897/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.